Published in PLoS One on July 09, 2015
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species. BMC Genomics (2016) 0.82
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet (2003) 9.13
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Biology of Bordetella bronchiseptica. Microbiol Rev (1980) 5.31
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J (1999) 3.29
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science (2004) 2.91
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Clonal diversity and host distribution in Bordetella bronchiseptica. J Bacteriol (1987) 2.59
Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun (1994) 2.39
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun (2008) 2.29
Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. J Clin Microbiol (1983) 2.17
Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology (1999) 1.94
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol Microbiol (1996) 1.72
Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun (1999) 1.59
Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci U S A (2004) 1.51
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
Evolution and emergence of Bordetella in humans. Trends Microbiol (2005) 1.25
Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology (1994) 1.25
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun (1997) 1.09
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance. PLoS One (2011) 0.92
Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol (2006) 0.86
Predisposition of specific pathogen-free lambs to Pasteurella haemolytica pneumonia by Bordetella parapertussis infection. J Comp Pathol (1995) 0.80
Pneumonia in lambs inoculated with Bordetella parapertussis: clinical and pathological studies. N Z Vet J (1988) 0.77